AM Best to Exhibit at Indonesia Rendezvous and Conference

OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best will participate at the 30th annual Indonesia Rendezvous and Conference, which will take place 12-15 October 2026, in Bali, Indonesia.

AM Best will be exhibiting at the event, and visitors to Booth #S7 can learn more about the resources AM Best offers to insurance professionals, including Best’s Credit Ratings and Best’s National Scale Rating for Indonesia. Additionally, Rob Curtis, managing director and chief executive officer of AM Best’s Asia Pacific operations, and Johnathan Wong, senior market development analyst, will be in attendance and will be available for meetings. To arrange a meeting with Curtis, please email [email protected], or [email protected] to meet with Wong.

This year marks 30th annual Indonesia Rendezvous and is themed as “Building Confidence: Driving Sustainable Growth and Resilience.” The event, which will be held at the Bali International Convention Centre, aims to produce solutions, insights and frameworks ahead of several major government policies and regulations coming into force that hold implications for insurers. To learn more about the event, visit here.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2026 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260930485773/en/

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
[email protected]

Cynthia Ang
Senior Industry Research Analyst
+65 6303 5026
[email protected]

Source: AM Best

You May Also Be Interested In

• FreeCast Provides Additional Detail on Previously Announced Fiscal 2026 Results
• LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas
• Man Group PLC : Form 8.3 - Vesuvius Plc